Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Neoadjuvant Short Course Radiotherapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer

NCT02270606 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT02270606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02270606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Neoadjuvant Short Course Radiotherapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Completed
Start date
December 4, 2014
Completion date
May 13, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucinous adenocarcinoma of the rectum, rectal adenocarcinoma, recurrent rectal cancer, signet ring adenocarcinoma of the rectum, stage iia rectal cancer, stage iib rectal cancer, stage iic rectal cancer, stage iiia rectal cancer, stage iiib rectal cancer, stage iiic rectal cancer